Navigation Links
Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
Date:3/16/2009

r child has blurred vision while taking Vyvanse.

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of research, development, approval, reimbursement, manufacturing and commercialization of the Company's Specialty Pharmaceutical and Human Genetic Therapies products, as well as the ability to secure and integrate new products for commercialization and/or development; government regulation of the Company's products; the Company's ability to manufacture its products in sufficient quantities to meet demand; the impact of competitive therapies on the Company's product
'/>"/>

SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
10. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
11. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... -- GenVec, Inc. (NASDAQ: GNVC ) today announced a ... and his team from the School of Medicine at ... (WUSTL).  Dr. Curiel is the director of the Biologic ... Department of Radiation Oncology. Under the ... versions of GenVec,s gorilla adenovectors that incorporate specialized targeting ...
(Date:6/3/2015)... June 3, 2015  Armetheon, Inc., a specialty ... cardiovascular diseases, today announced that Sanjay Kakkar ... Executive Officer, effective immediately. Dr. Kakkar brings more ... enterprises, with a successful track record in advancing ... With expertise that includes the development of novel ...
(Date:6/3/2015)... June 02, 2015 Research and Markets ( ... "Europe CT Market - Growth, Trends And Forecasts (2014 ... Computed tomography (CT) is an imaging process that customs ... images, or scans, of areas inside the body. It ... (CAT) scanning. It is primarily used in the Cancer ...
Breaking Medicine Technology:GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 2GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 3GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 4Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 2Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 4Europe CT Market Report 2015-2019 - Growth, Trends And Forecasts 2
... July 1 Caraco Pharmaceutical Laboratories, Ltd. (NYSE ... capsules. These products, approved by the US Food and ... Application (ANDA), are therapeutically equivalent to Exelon® capsules from ... to moderate Alzheimer,s dementia and mild to moderate Parkinson,s ...
... BEIJING , July 1 /PRNewswire-Asia-FirstCall/ ... the development, assembly, marketing and,sale of medical devices and homecare medical products ... Financial Officer, and Sam Shuguang Gui, Vice,President of Strategic Development, will present ... San Francisco, CA. , , ...
Cached Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Exelon® Capsules 2Dehaier Medical Systems to Present to Investors at Global Hunter Securities 2010 China Investor Conference in San Francisco 2Dehaier Medical Systems to Present to Investors at Global Hunter Securities 2010 China Investor Conference in San Francisco 3
(Date:6/3/2015)... Raleigh, NC (PRWEB) June 03, 2015 ... on two biomarkers for mesothelioma and say the tried-and-true ... has just posted an article on the research. ... in the University’s National Center for Asbestos Related Diseases ... false positive results, it is still preferable to fibulin-3 ...
(Date:6/3/2015)... Nashville, TN (PRWEB) June 03, 2015 ... Inquisitr police officers intercepted fake oxycodone pills ... fake pills were doctored to look legitimate, and even ... Police officers are warning those consuming 30 mg oxycodone ... order the pills online or buy them illegally on ...
(Date:6/3/2015)... June 03, 2015 Fourroux Prosthetics, located ... GA will celebrate its grand opening with a ribbon ... first prosthetic center of its kind in the area, ... unmatched care and outcomes through use of patented advanced ... & CEO of Fourroux Prosthetics, states, “Our goal has ...
(Date:6/3/2015)... DailyEndorphin is pleased to announce the launch ... this highly configurable new offering, DE's annual clients may ... of its wellness programming for the entire year as ... this new module, annual clients may also do the ... surveys, (3) Continually report on participant progress towards the ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 On May ... Marketing Authorization (MA), effective immediately, which now permits the ... that contain oats as ingredients. The MA is a ... developed. All stakeholders should be aware that, unlike the ... the USA, there are restrictions for gluten-free oat products ...
Breaking Medicine News(10 mins):Health News:Analysis Reveals Gold Standard Mesothelioma Biomarker Still the Best, According to Surviving Mesothelioma 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 3Health News:Fourroux Prosthetics Atlanta to Have Grand Opening Gala & Ribbon Cutting Ceremony 2Health News:DailyEndorphin Launches Wellness "Events" Portal 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 3
... proud to now serve as a presenting sponsor for the ... celebrates and supports the efforts to overcome cancer.ATLANTA, April 17 ... the science of cancer care, it,s easy to lose sight ... of the journey.Motivated by the Relay for Life events of ...
... As little as 10 minutes of exposure changes cardiovascular ... -- Cardiovascular function can be affected by as little ... other air pollutants such as wood smoke and smoke ... increasing evidence that higher levels of air pollution are ...
... study involves effort to improve chemotherapy effectiveness , , FRIDAY, April ... and testing, only a small percentage of cancer agents make ... come up with a way to weed out the duds ... marketplace. , The new model, a so-called "phase 0" ...
... April 17 In recognition of the 20th anniversary of ... global hemophilia community by pledging euro 250,000 to the World ... around the world will engage in activities to support the ... and promote support for the needs of people living with ...
... Ninety Percent of People Being Treated for Bipolar Disorder ... Depressive Symptoms (1)WASHINGTON, April 17 A ... living with bipolar disorder and 500 physicians who treat ... among people living with bipolar disorder (73%) is that ...
... making it possible to view the likely outcome of breast augmentation ... with McCormack Plastic Surgery is taking advantage of it. , ... ... asked by women considering breast surgery is typically: ‘What will I ...
Cached Medicine News:Health News:Elekta Sponsors All Are Our Heroes to Raise Cancer Awareness 2Health News:Elekta Sponsors All Are Our Heroes to Raise Cancer Awareness 3Health News:Secondhand Smoke Quickly Affects Blood Vessels 2Health News:'Phase 0' Trials Aim to Speed Cancer Drug Development 2Health News:'Phase 0' Trials Aim to Speed Cancer Drug Development 3Health News:Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia 2Health News:Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia 3Health News:Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia 4Health News:Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia 5Health News:New National Online Survey Says Bipolar Depressive Symptoms Have Impact on Day-To-Day Tasks as Well as Social Activities(1) 2Health News:New National Online Survey Says Bipolar Depressive Symptoms Have Impact on Day-To-Day Tasks as Well as Social Activities(1) 3Health News:New National Online Survey Says Bipolar Depressive Symptoms Have Impact on Day-To-Day Tasks as Well as Social Activities(1) 4Health News:New National Online Survey Says Bipolar Depressive Symptoms Have Impact on Day-To-Day Tasks as Well as Social Activities(1) 5Health News:Nevada Breast Augmentation Surgeon Gives Reno Patients a Glimpse of Likely Results with Portrait 3D Computer Imagery 2Health News:Nevada Breast Augmentation Surgeon Gives Reno Patients a Glimpse of Likely Results with Portrait 3D Computer Imagery 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: